Neurology News

CHICAGO — Continuous subcutaneous apomorphine infusion reduced “off” time and increased “on” time without troublesome dyskinesia in patients with Parkinson’s disease in the United States, with no new safety signals reported.

President Joe Biden today announced his intention to nominate NCI director Monica M. Bertagnolli, MD, FACS, FASCO, as director of the NIH.

CHICAGO — Researchers have reported a link between a novel DCTN1 variant and Perry syndrome, which was identified both in asymptomatic individuals and those with mild neurological abnormalities, suggesting a prodromal stage of disease.

Significant racial and ethnic inequities persist in all aspects of stroke care, yet interventions that adequately address social determinants of health and other related factors are lacking, according to a new scientific statement.

CHICAGO – The Huntington Disease Health Index was an accurate, clinically meaningful tool for participants in the KINECT-HD trial to report symptomatic disease burden changes when treated with valbenazine, according to a recent study.

May is Brain Cancer Awareness Month.

CHICAGO — The International Association of Parkinsonism and Related Disorders has honored three young investigators for their outstanding research related to Parkinson’s disease.

Access to early amyloid position emission tomography allowed those with memory issues to receive a diagnosis with very high confidence at 3 months compared with those who did not undergo PET, according to research in JAMA Neurology.

Investors often hear the phrase “don’t put all your eggs in one basket,” and interpret it as a warning against owning too much of one individual stock in a portfolio.

The FDA has approved expanded MRI labeling for Abbott’s Eterna spinal cord stimulation system, allowing those with chronic pain to undergo MRI within specific conditions and have a wider selection of lead options for full-body scans.